Introduction
Vagus nerve stimulation (VNS) has been developed as an add-on treatment for patients with pharmacoresistant epilepsy, who are unsuitable candidates for curative resective surgery or who have experienced insufficient benefit from such a treatment. 1 Based on clinical observations in epileptic patients with comorbid disorders, VNS has also been explored as a treatment for mood and cognitive disorders, such as depression, 2, 3 anxiety, 4, 5 Alzheimer's disease, 6 and also for migraine. 7 The present article provides a review of recently published data on the effects of VNS on cognition and memory. The importance of demonstrating a possible cognitive effect (e.g. increased attention and memory performance) of VNS lies in a better understanding of the mechanisms of memory. If it could be demonstrated that VNS-patients experience a positive cognitive effect, the therapy may be considered for a wide variety of patients with cognitive impairment such as patients with traumatic injury or degenerative disease. 8 Until now, only two clinical reviews have been published specifically looking at cognitive effects of VNS. 9, 10 There are many reasons to assume an effect of VNS on cognition. The nucleus of the solitary tract (NST) in the brain stem is the main relay station for afferent vagal nerve fibers. This nucleus has widespread projections to numerous areas in the forebrain as well as the brain stem, including areas involved in learning and memory formation (amygdala, hippocampus). Stimulation of the vagus nerve induces Seizure (2006) Summary Vagus nerve stimulation (VNS) has been developed as an add-on treatment for patients with refractory epilepsy. Based on the clinical observation of improved cognition in many epilepsy patients who received VNS, we reviewed the recent literature for evidence concerning the cognitive effects of this treatment. From most of these studies it seems that, with currently used stimulation parameters, the effects on memory are only of theoretical importance. However, some animal studies suggest positive effects on specific modalities of memory function. In studies in epilepsy patients, there is no evidence of adverse effects on cognition but clear-cut positive effects cannot be expected either. Preliminary results of VNS in the treatment of diseases associated with cognitive decline such as Alzheimer's disease seem promising but need to be further investigated. # 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. changes in the electrophysiological and metabolic profile of these brain structures. 8 It appeared from studies designed to evaluate the side-effects of VNS that epileptic patients who received VNS have improved cognition. Moreover, it is believed that substances that stimulate learning and memory exert their effect through activation of peripheral receptors that send neural information to the central nervous system through the vagus nerve.
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Methods
A Pubmed (public domain of the electronic database of the National Library of Medicine) literature search was performed, the selection was made for articles written in English in the past 10 years (1995-2005) using the following keywords: vagus nerve stimulation (VNS), cognition and memory. Both animal and human studies were selected. Manuscripts dealing with the effect of VNS on mood were not considered.
Results
Effects of VNS on cognition have been described in animal experiments and human studies; the methodologies used in these different studies varied accordingly. The animal studies evaluated the memory of rats in an experimental study based on a onetrial inhibitory-avoidance task. 11, 12 Three of the human studies were longitudinal follow-up studies in which the baseline condition was compared with the condition after stimulation of the vagus nerve in epileptic patients. [13] [14] [15] Two studies used a comparable protocol in depressive patients 16 and in patients with Alzheimer's disease. 6 Clark et al. 8 and Helmstaedter et al. 17 investigated the acute effects of VNS on memory in a controlled trial in patients. Dodrill and Morris 18 compared the effects of two stimulation conditions (high versus low output current) in a double-blind efficacy study in epileptic patients.
Discussion Animal experiments
Clark et al. 11 studied the affective memory with a one-trial inhibitory-avoidance task in rats receiving post-training vagus nerve stimulation (stimulation parameters: 500 ms, 20 Hz, 30 s), compared to rats who received no stimulation. The inhibitory-avoidance task consisted of an electrical foot shock administered when the animal enters a darkened room. Retention to enter the darkened room is tested 24 h later. There was a significantly improved retention performance in rats who received stimulation with an output current of 0.4 mA (>10 min latency), but not with 0.2 mA or 0.8 mA, compared with rats who received sham stimulation (<1 min latency). Retention performance in function of output current was an inverted U-shaped function. This is comparable to the typical dose-response relation of many other memory-enhancing agents. 8 Clark et al. concluded that the vagus nerve plays an important role in modulating memory consolidation processes. From this study, however, it was not clear whether the retention performance was influenced by efferents or afferents of the vagus nerve. Therefore, Clark et al. repeated the study in 1998 with the same protocol, 12 but inactivated descending fibres below the point of stimulation by infusion of lidocaïne. Control rats received infusion of saline. The memory of the rats was enhanced regardless whether descending vagus nerve fibres were inactivated or not. This lead to the conclusion that vagal efferents were probably not important in modulating memory processes. According to the authors, the positive effects on memory may be important in daily life of the patients, because VNS does not only stimulate the memory structures directly, but might also induce secondary processes such as involving a relative hyperglycaemic state, providing more free glucose to the brain and enhancing memory storage processes. 12 
Human research
Clarke et al. 13 tested the reaction time (simple and complex tests) in epilepsy patients before and after long-term VNS (total duration of VNS of 28 months; stimulation parameters: 500 ms, 30 Hz). No adverse effects for simple reaction time tests or for the more complex cognitive motor reaction time tests were demonstrated. In some tests improvement was shown. Absence of general improvement was attributed, in part, to the chronic long-term effects of antiepileptic drugs and/or the natural history of complex partial seizures. From this human study Clarke et al. concluded that chronic VNS did not impair cognitive motor control.
In another study, Clark et al. 8 studied word recognition-memory in epileptic patients. The patients received VNS (stimulation parameters: 500 ms, 30 Hz, 30 s on) (n = 5) or sham stimulation (n = 5) after reading a paragraph with high-lighted words, during the consolidation process of the memory. There was a better recognition of highlighted words from a list of distracter nouns in paragraphs followed by VNS compared to control paragraphs. Memory retention after VNS appeared to be intensity dependent: memory retention in function of output current was an inverted Ushaped function with the maximum at 0.5 mA (compared to $0.4 mA in rats). 11, 12 A reduction in number, duration or frequency of epileptic seizures did not contribute to the observed improvement in retention performance. The investigators concluded that VNS enhanced verbal memory in humans. They also concluded that the processes that modulate memory formation are likely to be similar regardless of the nature of the memory (affective versus verbal) or the particular mammalian species in which the memory develops (rats versus humans). 8, 11, 12 Hoppe et al. 14 could not detect pre-post changes of attention, motor functioning, short-term memory, learning and memory and executive functions in 36 epilepsy patients (26 males/10 females) before and after 6 months of VNS (stimulation parameters: 500 ms, 30 Hz, 30 s on/300 s off). They concluded that the effects described by Clark et al. are theoretical and have no impact on daily life. In the study of Clark et al. VNS was administered at a specific point of time in the learning process, but in daily life VNS is delivered ''randomly'' according to a fixed duty cycle. Moreover, the clinically used stimulation output is usually higher (1-3 mA) than the effective output current used in the study of Clark et al. (0.50 mA).
A possible negative impact of VNS on memory was described in 11 epilepsy patients by Helmstaedter et al. 17 VNS (acute stimulation; stimulation parameters: 500 ms, 30 Hz, 30 s on/4.5 min off, 1-2.5 mA) administered during presentation and recognition of words and designs resulted in a deterioration of figural memory, but not verbal memory. The observed deterioration was fully reversible. The acute stimulation conditions in this study were different from chronic stimulation that is applied in the clinical context. Hence, negative cognitive side effects in VNS treated patients are unlikely. Moreover, during VNS there was an improvement of decision times, which rather indicates a positive effect of VNS on attention.
The different results of Clark et al. 8 and Helmstaedter et al. 17 with regard to verbal memory (positive change versus no change, respectively) could be explained by the fact that the output current was lower in the study of Clark et al. (<1 mA versus >1 mA in the study of Helmstaedter et al.). Moreover, VNS was given at different points of time in the learning process: Clark et al. administered VNS during memory consolidation, Helmstaedter et al. during learning and recognition. Table 1 summarizes the general results of studies on the effect of VNS on memory.
Dodrill and Morris 18 stated that VNS was not associated with any negative impact on cognition by studying cognitive functions other than memory in epilepsy patients before and after 12-16 weeks of VNS. They compared a high and low stimulation group. Results of baseline-to-treatment period changes across the low and high groups showed no statistically significant differences in the cognitive tests.
A similar result was found by Hallböök et al. 15 in epileptic children before and after 3 and 9 months of VNS (stimulation parameters: 500 ms, 30Hz, 30 s, 1-1.5 mA). Cognitive abilities, quality of life (QOL), behaviour and mood were tested. No early changes in cognitive functioning were detected, but there seemed to be a gradual improvement over time. Therefore, it is likely that a longer study period is needed to detect significant cognitive changes.
In depressed patients improvement of motor speed, psychomotor function, language and executive functions were observed after 10 weeks of VNS (duty cycle: 30 s on/5 min off). 16 Cognitive improvement, however, was primarily found among patients who showed clinical improvement. Therefore, the data are difficult to interpret, especially with regard to extrapolating positive results to patients with Alzheimer' disease. 9 In addition, no linear relation was shown between output current and changes in cognitive parameters. The sample size was too small and the distribution of the maximal output current was too wide to show a non-linear relation, similar to the U-shaped function found by Clark et al. 8, 11, 12 Vagus nerve stimulation and cognition 261 In Alzheimer patients, there is a suggestion of a positive effect of VNS on cognitive function. Sjogren et al. 6 studied the scores of 10 Alzheimer patients on the Alzheimer' disease assessment scale-cognition subscale (ADAS-cog) and the mini mental state examination (MMSE) at baseline, and after 3 and 6 months of VNS. Seven out of 10 patients were considered responders showing cognitive improvement. Because of the progressive nature of Alzheimer's disease, the low sample size and the relatively short study period it remains difficult to conclude that these initial positive results truly suggest that VNS can be considered a treatment for Alzheimer's disease.
9 Table 2 summarizes the results of studies on the cognitive effects of VNS.
Conclusion
In animal studies, a clear-cut memory-enhancing effect was observed after vagus nerve stimulation in rats. These effects could not be replicated in human studies. As the few observations of a negative effect of VNS on some modalities of memory in humans were fully reversible and important differences between the experimental and therapeutic stimulation conditions existed, these findings are probably not significant for the everyday life of patients treated with VNS. The positive effects of VNS on memory reported in the animal studies probably also have a rather theoretical impact with regard to the vagus nerve-brain interactions, but are not significant for the daily life of VNS-treated patients either. There is no evidence in favour of adverse cognitive effects of VNS, but most studies suggest that clear-cut positive effects cannot be expected either. The positive effects of VNS observed in patients with Alzheimer's disease need to be further investigated using double-blind randomized study designs.
